Literature DB >> 11899285

Immunotherapy for food allergy.

L G Wild1, S B Lehrer.   

Abstract

Food allergy is an important cause of life-threatening hypersensitivity reactions. Avoidance of allergenic foods is the only method of prevention that currently is available for sensitized patients. This method of prevention is difficult and often impossible. With better characterization of allergens and better understanding of the immunologic mechanism, investigators have developed several therapeutic modalities that potentially are applicable to the treatment and prevention of food allergy. Therapeutic options currently under investigation include peptide immunotherapy, DNA immunization, immunization with immunostimulatory sequences, anti-IgE therapy, and genetic modification of foods. These exciting developments hold promise for the safe and effective treatment and prevention of food allergy in the next several years.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899285     DOI: 10.1007/s11882-001-0096-1

Source DB:  PubMed          Journal:  Curr Allergy Rep


  30 in total

1.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

2.  Pepsin-digested peanut contains T-cell epitopes but no IgE epitopes.

Authors:  S J Hong; J G Michael; A Fehringer; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1999-08       Impact factor: 10.793

Review 3.  Peanut allergy.

Authors:  C Loza; J Brostoff
Journal:  Clin Exp Allergy       Date:  1995-06       Impact factor: 5.018

4.  Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization.

Authors:  C H Hsu; K Y Chua; M H Tao; Y L Lai; H D Wu; S K Huang; K H Hsieh
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

5.  Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro.

Authors:  B Bohle; B Jahn-Schmid; D Maurer; D Kraft; C Ebner
Journal:  Eur J Immunol       Date:  1999-07       Impact factor: 5.532

6.  Treatment of cat allergy with T-cell reactive peptides.

Authors:  P S Norman; J L Ohman; A A Long; P S Creticos; M A Gefter; Z Shaked; R A Wood; P A Eggleston; K B Hafner; P Rao; L M Lichtenstein; N H Jones; C F Nicodemus
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

7.  IgE reactivity against a cross-reactive allergen in crustacea and mollusca: evidence for tropomyosin as the common allergen.

Authors:  P S Leung; W K Chow; S Duffey; H S Kwan; M E Gershwin; K H Chu
Journal:  J Allergy Clin Immunol       Date:  1996-11       Impact factor: 10.793

8.  Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

Authors:  K Roy; H Q Mao; S K Huang; K W Leong
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

9.  An investigation of the possible immunological relationship between allergen extracts from birch pollen, hazelnut, potato and apple.

Authors:  K E Andersen; H Løwenstein
Journal:  Contact Dermatitis       Date:  1978-04       Impact factor: 6.600

10.  Treatment of peanut allergy with rush immunotherapy.

Authors:  J J Oppenheimer; H S Nelson; S A Bock; F Christensen; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1992-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.